Search Results

Carl Zeiss Meditec and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, announced that the companies have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial keratoplasty and natural lenticule transplants for treating keratoconus and vision correction.

GenScript, a leading provider of life science research and application services, proudly announced that Dr. Carl June, a distinguished figure in the field of immunotherapy, has joined the company’s scientific advisory board.

ZEISS is unveiling two highlights at M&M 2023, in Minneapolis, MN, from July 23 to July 27, 2023.

Boehringer Ingelheim and ZEISS Medical Technology announce today a long-term strategic collaboration to develop predictive analytics to enable early detection of eye diseases and prevent vision loss for people with serious eye diseases.

Zerion Pharma A/S (“ZERION”) today announces that the Company has elected Mr. Carl-Åke Carlsson as its new Chairman of the Board of Directors.

BioAI Health, a leader in AI-powered precision medicine, today announced the appointment of Dr. J. Carl Barrett, PhD to its Scientific Advisory Board.

ZEISS Research Microscopy Solutions announced its new microsite featuring nine researchers and 24 areas of study, to celebrate the amazing breakthroughs these scientists are achieving with ZEISS instruments.

This Pheo Para Awareness Week, The Carling Adrenal Center is working to bring attention to the prevalence of pheochromocytoma and paraganglioma, which are neuroendocrine tumors that make excess adrenaline.

Illumina today issued the following response to Carl Icahn’s public statements and letters to Illumina’s shareholders dated March 13 and March 15, 2023.